The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. As of today, Formycon AG's share price is €42.15.
Formycon AG's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2023 was €4.85. Hence, Formycon AG's PS Ratio for today is 8.70.
Good Sign:
Formycon AG stock PS Ratio (=8.71) is close to 3-year low of 7.98
The historical rank and industry rank for Formycon AG's PS Ratio or its related term are showing as below:
XTER:FYB'
s PS Ratio Range Over the Past 10 Years
Min: 5.1 Med: 15.35 Max: 270
Current: 8.7
During the past 13 years, Formycon AG's highest PS Ratio was 270.00. The lowest was 5.10. And the median was 15.35.
XTER:FYB's PS Ratio is ranked better than 51.3% of 1000
companies
in the Biotechnology industry
Industry Median: 9.055
vs XTER:FYB: 8.70
During the past 12 months, the average Revenue per Share Growth Rate of Formycon AG was 58.20% per year.
During the past 3 years, the average Revenue per Share Growth Rate was 13.00% per year.
During the past 5 years, the average Revenue per Share Growth Rate was 0.10% per year.
During the past 10 years, the average Revenue per Share Growth Rate was 28.50% per year.
During the past 13 years, Formycon AG's highest 3-Year average Revenue per Share Growth Rate was 296.10% per year. The lowest was -10.40% per year. And the median was 29.80% per year.
Back to Basics: PS Ratio
Formycon AG PS Ratio Historical Data
The historical data trend for Formycon AG's PS Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Biotechnology subindustry, Formycon AG's PS Ratio, along with its competitors' market caps and PS Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Formycon AG's PS Ratio Distribution in the Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Formycon AG's PS Ratio distribution charts can be found below:
* The bar in red indicates where Formycon AG's PS Ratio falls into.
Formycon AG PS Ratio Calculation
The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. It is a ratio widely used to value stocks and it was first used by Ken Fisher.
Formycon AG's Share Price of today is €42.15.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Formycon AG's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2023 was €4.85.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
The PS Ratio is an excellent valuation indicator if you want to compare a stock with its historical valuation or with the stocks in the same industry. The PS Ratio works especially well when you want to compare the stock's current valuation with its historical valuation. The PS Ratio is a great valuation tool for evaluating cyclical businesses where the PE Ratio works poorly. It works the best when comparing the current valuation with the historical valuation because over time, a company's profit margin tends to revert to the mean.
When the PS Ratio is applied to the whole stock market, it can be used to evaluate the current market valuation and projected returns. In this case, the price is the total market cap of all stocks that are traded, and sales are the GDP of the country. This is how Warren Buffett estimates the broad market valuation and project future returns.
The PS Ratio does not tell you how cheap or expensive the stock is. It cannot be used to compare companies in different industries. It works better for companies within the same industry because these companies tend to have similar capital structures and profit margins. It works the best when comparing a company with itself in the past.
Formycon AG PS Ratio Related Terms
Thank you for viewing the detailed overview of Formycon AG's PS Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.
Formycon AG is a pharmaceutical company. It is engaged in the development of pharmaceutical and biopharmaceutical products and the development of drug delivery systems. Its focus is on treatments in ophthalmology and immunology as well as other chronic diseases. The company's pipeline in the biosimilar drugs category includes FYB201, FYB202, FYB203, and FYB207 for the treatment of COVID 19. It is also engaged in the provision of diagnostic laboratory services and works for third parties and the carrying out of diagnostic laboratory services.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
XTER:FYB has been successfully added to your 